Latest Share Options News

Turners Automotive Group has issued over 180,000 new shares through its Dividend Reinvestment Plan and option exercises, subtly reshaping its capital structure as FY26 progresses.

BPH Energy’s December quarter report reveals significant progress in its investee projects amid ongoing legal challenges and strategic capital management. The company balances judicial reviews, regulatory milestones, and funding plans across energy and medical technology sectors.

Energy Resources of Australia reported a $45.3 million operating cash outflow in Q4 2025 but maintains robust liquidity from a prior $766 million capital raise, supporting operations through 2027.

Desert Metals Limited has completed the second tranche of its placement, raising a total of $1.25 million through new shares and options issued to investors and its lead manager.

DroneShield Limited has triggered the vesting of over 9 million performance options following a significant $200 million cash receipts milestone, reflecting rapid growth and a new incentive framework.

Pilot Energy is seeking shareholder approval for a 1-for-25 consolidation of its securities to streamline its capital structure and boost investor appeal as it advances into carbon storage and clean energy projects.

Global Uranium and Enrichment Limited has finalised the share and option scheme considerations for its acquisition by Snow Lake Resources, with directors backing the deal ahead of the upcoming shareholder vote.

Critica Limited has successfully closed the second tranche of its $8 million placement, issuing over 92 million shares and options to accelerate development at its Jupiter Rare Earth Project.

Noble Helium has restructured its VAT shortfall loan, extending maturity to mid-2027 and raising $2.15 million through a convertible loan note to support its strategic turnaround and Rukwa drilling program.

Eagle Mountain Mining has closed its entitlement offer, raising just over half of its targeted $1.98 million, with a significant shortfall to be placed alongside lead managers. The funds will support its copper-gold exploration projects in Arizona.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.

InhaleRx Limited has completed the final tranche of its share placement, raising $600,000 to support its clinical-stage drug development programs targeting pain and mental health.